S100A8 induces IL-10 and protects against acute lung injury

Journal of Immunology

Volumn 192, Issue 6, 2014, Pages 2800-2811

  Hiroshima, Yuka ^a   Hsu, Kenneth ^a   Tedla, Nicodemus ^a   Chung, Yuen Ming ^a   Chow, Sharron ^a   Herbert, Cristan ^a   Geczy, Carolyn L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CALGRANULIN A; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 18 BINDING PROTEIN; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DOWN REGULATION; DRUG EFFECT; DRUG POTENCY; EPITHELIUM CELL; FEMALE; GENE CLUSTER; GENE REPRESSION; IMMUNOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTRACELLULAR SIGNALING; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION;

ACUTE LUNG INJURY; ADMINISTRATION, INTRANASAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CALGRANULIN A; CLUSTER ANALYSIS; DEXAMETHASONE; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED BALB C; MUTANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84897544193     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302556     Document Type: Article

References (50)

1. Vogl, T., K. Tenbrock, S. Ludwig, N. Leukert, C. Ehrhardt, M. A. van Zoelen, W. Nacken, D. Foell, T. van der Poll, C. Sorg, and J. Roth. 2007. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13: 1042-1049.
2. Boyd, J. H., B. Kan, H. Roberts, Y. Wang, and K. R. Walley. 2008. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ. Res. 102: 1239-1246.
3. Lorenz, E., M. S. Muhlebach, P. A. Tessier, N. E. Alexis, R. Duncan Hite, M. C. Seeds, D. B. Peden, and W. Meredith. 2008. Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases. Respir. Med. 102: 567-573.
4. Roth, J., S. Teigelkamp, M. Wilke, L. Grün, B. Tümmler, and C. Sorg. 1992. Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology 186: 304-314.
5. Foell, D., H. Wittkowski, T. Vogl, and J. Roth. 2007. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 81: 28-37.
6. Hsu, K., C. Champaiboon, B. D. Guenther, B. S. Sorenson, A. Khammanivong, K. F. Ross, C. L. Geczy, and M. C. Herzberg. 2009. Anti-infective protective properties of S100 calgranulins. Antiinflamm. Antiallergy Agents Med. Chem. 8: 290-305.
7. Endoh, Y., Y. M. Chung, I. A. Clark, C. L. Geczy, and K. Hsu. 2009. IL-10-dependent S100A8 gene induction in monocytes/macrophages by doublestranded RNA. J. Immunol. 182: 2258-2268.
8. Xu, K., T. Yen, and C. L. Geczy. 2001. Il-10 up-regulates macrophage expression of the S100 protein S100A8. J. Immunol. 166: 6358-6366.
9. Goyette, J., and C. L. Geczy. 2011. Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids 41: 821-842.
10. Cornish, C. J., J. M. Devery, P. Poronnik, M. Lackmann, D. I. Cook, and C. L. Geczy. 1996. S100 protein CP-10 stimulates myeloid cell chemotaxis without activation. J. Cell. Physiol. 166: 427-437.
11. Lim, S. Y., M. J. Raftery, and C. L. Geczy. 2011. Oxidative modifications of DAMPs suppress inflammation: the case for S100A8 and S100A9. Antioxid. Redox Signal. 15: 2235-2248.
12. Gomes, L. H., M. J. Raftery, W. X. Yan, J. D. Goyette, P. S. Thomas, and C. L. Geczy. 2013. S100A8 and S100A9-oxidant scavengers in inflammation. Free Radic. Biol. Med. 58: 170-186.
13. Zhao, J., I. Endoh, K. Hsu, N. Tedla, Y. Endoh, and C. L. Geczy. 2011. S100A8 modulates mast cell function and suppresses eosinophil migration in acute asthma. Antioxid. Redox Signal. 14: 1589-1600.
14. Hsu, K., R. J. Passey, Y. Endoh, F. Rahimi, P. Youssef, T. Yen, and C. L. Geczy. 2005. Regulation of S100A8 by glucocorticoids. J. Immunol. 174: 2318-2326.
15. Bozinovski, S., M. Cross, R. Vlahos, J. E. Jones, K. Hsuu, P. A. Tessier, E. C. Reynolds, D. A. Hume, J. A. Hamilton, C. L. Geczy, and G. P. Anderson. 2005. S100A8 chemotactic protein is abundantly increased, but only a minor contributor to LPS-induced, steroid resistant neutrophilic lung inflammation in vivo. J. Proteome Res. 4: 136-145.
16. Bonfield, T. L., M. W. Konstan, P. Burfeind, J. R. Panuska, J. B. Hilliard, and M. Berger. 1995. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 13: 257-261.
17. Takanashi, S., Y. Hasegawa, Y. Kanehira, K. Yamamoto, K. Fujimoto, K. Satoh, and K. Okamura. 1999. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur. Respir. J. 14: 309-314.
18. Iismaa, S. E., S. Hu, M. Kocher, M. Lackmann, C. A. Harrison, S. Thliveris, and C. L. Geczy. 1994. Recombinant and cellular expression of the murine chemotactic protein, CP-10. DNA Cell Biol. 13: 183-192.
19. Kurowska-Stolarska, M., B. Stolarski, P. Kewin, G. Murphy, C. J. Corrigan, S. Ying, N. Pitman, A. Mirchandani, B. Rana, N. van Rooijen, et al. 2009. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 183: 6469-6477.
20. Chung, Y. M., J. Goyette, N. Tedla, K. Hsu, and C. L. Geczy. 2013. S100A12 suppresses pro-inflammatory, but not pro-thrombotic functions of serum amyloid A. PLoS ONE 8: e62372.
21. Monick, M. M., L. S. Powers, T. J. Gross, D. M. Flaherty, C. W. Barrett, and G. W. Hunninghake. 2006. Active ERK contributes to protein translation by preventing JNK-dependent inhibition of protein phosphatase 1. J. Immunol. 177: 1636-1645.
22. McCormick, M. M., F. Rahimi, Y. V. Bobryshev, K. Gaus, H. Zreiqat, H. Cai, R. S. Lord, and C. L. Geczy. 2005. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J. Biol. Chem. 280: 41521-41529.
23. Harrison, C. A., M. J. Raftery, J. Walsh, P. Alewood, S. E. Iismaa, S. Thliveris, and C. L. Geczy. 1999. Oxidation regulates the inflammatory properties of the murine S100 protein S100A8. J. Biol. Chem. 274: 8561-8569.
24. Raftery, M. J., Z. Yang, S. M. Valenzuela, and C. L. Geczy. 2001. Novel intraand inter-molecular sulfinamide bonds in S100A8 produced by hypochlorite oxidation. J. Biol. Chem. 276: 33393-33401.
25. Sun, Y., Y. Lu, C. G. Engeland, S. C. Gordon, and H. Y. Sroussi. 2013. The antioxidative, anti-inflammatory, and protective effect of S100A8 in endotoxemic mice. Mol. Immunol. 53: 443-449.
26. Bozinovski, S., M. Uddin, R. Vlahos, M. Thompson, J. L. McQualter, A. S. Merritt, P. A. Wark, A. Hutchinson, L. B. Irving, B. D. Levy, and G. P. Anderson. 2012. Serum amyloid A opposes lipoxin A4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proc. Natl. Acad. Sci. USA 109: 935-940.
27. Murray, P. J. 2006. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr. Opin. Pharmacol. 6: 379-386.
28. Cheng, P., C. A. Corzo, N. Luetteke, B. Yu, S. Nagaraj, M. M. Bui, M. Ortiz, W. Nacken, C. Sorg, T. Vogl, et al. 2008. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med. 205: 2235-2249.
29. Chaurasia, B., J. Mauer, L. Koch, J. Goldau, A. S. Kock, and J. C. Brüning. 2010. Phosphoinositide-dependent kinase 1 provides negative feedback inhibition to Toll-like receptor-mediated NF-kappaB activation in macrophages. Mol. Cell. Biol. 30: 4354-4366.
30. Lawrence, T., M. Bebien, G. Y. Liu, V. Nizet, and M. Karin. 2005. IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434: 1138-1143.
31. Ligeti, E., R. Csépányi-Kömi, and L. Hunyady. 2012. Physiological mechanisms of signal termination in biological systems. Acta Physiol. (Oxf.) 204: 469-478.
32. Björk, P., A. Björk, T. Vogl, M. Stenström, D. Liberg, A. Olsson, J. Roth, F. Ivars, and T. Leanderson. 2009. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol. 7: e97.
33. Sukkar, M. B., M. A. Ullah, W. J. Gan, P. A. Wark, K. F. Chung, J. M. Hughes, C. L. Armour, and S. Phipps. 2012. RAGE: a new frontier in chronic airways disease. Br. J. Pharmacol. 167: 1161-1176.
34. Lackmann, M., P. Rajasekariah, S. E. Iismaa, G. Jones, C. J. Cornish, S. Hu, R. J. Simpson, R. L. Moritz, and C. L. Geczy. 1993. Identification of a chemotactic domain of the pro-inflammatory S100 protein CP-10. J. Immunol. 150: 2981-2991.
35. Garantziotis, S., D. M. Brass, J. Savov, J. W. Hollingsworth, E. McElvania-TeKippe, K. Berman, J. K. Walker, and D. A. Schwartz. 2006. Leukocytederived IL-10 reduces subepithelial fibrosis associated with chronically inhaled endotoxin. Am. J. Respir. Cell Mol. Biol. 35: 662-667.
36. Bosmann, M., N. F. Russkamp, and P. A. Ward. 2012. Fingerprinting of the TLR4-induced acute inflammatory response. Exp. Mol. Pathol. 93: 319-323.
37. Ichikawa, A., K. Kuba, M. Morita, S. Chida, H. Tezuka, H. Hara, T. Sasaki, T. Ohteki, V. M. Ranieri, C. C. dos Santos, et al. 2013. CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am. J. Respir. Crit. Care Med. 187: 65-77.
38. Sica, A., and A. Mantovani. 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122: 787-795.
39. Sroussi, H. Y., Y. Lu, Q. L. Zhang, D. Villines, and P. T. Marucha. 2010. S100A8 and S100A9 inhibit neutrophil oxidative metabolism in-vitro: involvement of adenosine metabolites. Free Radic. Res. 44: 389-396.
40. Ikemoto, M., H. Murayama, H. Itoh, M. Totani, and M. Fujita. 2007. Intrinsic function of S100A8/A9 complex as an anti-inflammatory protein in liver injury induced by lipopolysaccharide in rats. Clin. Chim. Acta 376: 197-204.
41. Lim, S. Y., M. Raftery, H. Cai, K. Hsu, W. X. Yan, H. L. Hseih, R. N. Watts, D. Richardson, S. Thomas, M. Perry, and C. L. Geczy. 2008. S-nitrosylated S100A8: novel anti-inflammatory properties. J. Immunol. 181: 5627-5636.
42. Ray, P. D., B. W. Huang, and Y. Tsuji. 2012. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 24: 981-990.
43. Zhang, W. J., H. Wei, Y. T. Tien, and B. Frei. 2011. Genetic ablation of phagocytic NADPH oxidase in mice limits TNFa-induced inflammation in the lungs but not other tissues. Free Radic. Biol. Med. 50: 1517-1525.
44. Rocksén, D., B. Lilliehöök, R. Larsson, T. Johansson, and A. Bucht. 2000. Differential anti-inflammatory and anti-oxidative effects of dexamethasone and N-acetylcysteine in endotoxin-induced lung inflammation. Clin. Exp. Immunol. 122: 249-256.
45. Millea, P. J. 2009. N-acetylcysteine: multiple clinical applications. Am. Fam. Physician 80: 265-269.
46. Günzl, P., K. Bauer, E. Hainzl, U. Matt, B. Dillinger, B. Mahr, S. Knapp, B. R. Binder, and G. Schabbauer. 2010. Anti-inflammatory properties of the PI3K pathway are mediated by IL-10/DUSP regulation. J. Leukoc. Biol. 88: 1259-1269.
47. Luchetti, F., M. Betti, B. Canonico, M. Arcangeletti, P. Ferri, F. Galli, and S. Papa. 2009. ERK MAPK activation mediates the antiapoptotic signaling of melatonin in UVB-stressed U937 cells. Free Radic. Biol. Med. 46: 339-351.
48. Hernández, G., H. Lal, M. Fidalgo, A. Guerrero, J. Zalvide, T. Force, and C. M. Pombo. 2011. A novel cardioprotective p38-MAPK/mTOR pathway. Exp. Cell Res. 317: 2938-2949.
49. Masuda, A., Y. Yoshikai, K. Aiba, and T. Matsuguchi. 2002. Th2 cytokine production from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N-terminal kinase and p38 pathways. J. Immunol. 169: 3801-3810.
50. Coutinho, A. E., J. K. Brown, F. Yang, D. G. Brownstein, M. Gray, J. R. Seckl, J. S. Savill, and K. E. Chapman. 2013. Mast cells express 11β-hydroxysteroid dehydrogenase type 1: a role in restraining mast cell degranulation. PLoS ONE 8: e54640.